Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Successful treatment of hepatosplenic T-cell lymphoma with ESHAP followed by autologous stem cell transplant.

Chalmers AW, Katz DA, Miller IJ, Gregory SA.

Clin Adv Hematol Oncol. 2013 Feb;11(2):109-13. No abstract available.

PMID:
23598914
2.

Hepatosplenic T-cell lymphoma: is cure possible?

Shustov A.

Clin Adv Hematol Oncol. 2013 Feb;11(2):113-5. Review. No abstract available.

PMID:
23598915
3.

Hepatosplenic alphabeta T cell lymphoma.

Nagai Y, Ikegame K, Mori M, Inoue D, Kimura T, Shimoji S, Togami K, Tabata S, Kurata M, Imai Y, Matsushita A, Nagai K, Ogawa H, Takahashi T.

Int J Clin Oncol. 2010 Apr;15(2):215-9. doi: 10.1007/s10147-010-0028-y.

PMID:
20217452
4.

Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma.

Puig N, Wang L, Seshadri T, al-Farsi K, Keating A, Crump M, Kuruvilla J.

Leuk Lymphoma. 2013 Mar;54(3):507-13. doi: 10.3109/10428194.2012.719615.

PMID:
22897731
5.

R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous stem-cell transplantation on outcome.

Martín A, Caballero MD; Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea..

Haematologica. 2009 May;94(5):744. doi: 10.3324/haematol.2009.006452. No abstract available.

6.

ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF.

Lee JL, Kim S, Kim SW, Kim EK, Kim SB, Kang YK, Lee J, Kim MW, Park CJ, Chi HS, Huh J, Kim SH, Suh C.

Bone Marrow Transplant. 2005 Mar;35(5):449-54.

PMID:
15654353
7.

A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.

Mittal S, Milner BJ, Johnston PW, Culligan DJ.

Eur J Haematol. 2006 Jun;76(6):531-4.

PMID:
16548918
8.

Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects.

D'Sa S, Yong K, Kyriakou C, Bhattacharya S, Peggs KS, Foulkes B, Watts MJ, Ings SJ, Ardeshna KM, Goldstone AH, Williams CD.

Br J Haematol. 2004 Jun;125(6):756-65.

PMID:
15180865
9.

High-dose therapy supported by autologous stem cell transplantation in patients with enteropathy-associated T-cell lymphoma.

Jantunen E, Juvonen E, Wiklund T, Putkonen M, Nousiainen T.

Leuk Lymphoma. 2003 Dec;44(12):2163-4. No abstract available.

PMID:
14959866
11.
12.

Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: results of a single-center study of 32 patients. Modified etoposide, methylprednisolone, cytarabine and cisplatin.

Oztürk MA, Barişta I, Altundağ MK, Türker A, Yalçin S, Celik I, Güllü I, Güler N, Ozişik Y, Kars A, Kansu E, Baltali E, Tekuzman G.

Chemotherapy. 2002 Dec;48(5):252-8.

PMID:
12476042
13.

Intensive chemotherapy with hematopoietic cell transplantation after ESHAP therapy for relapsed or refractory non-Hodgkin's lymphoma. Results of a single-centre study of 65 patients.

Soussain C, Souleau B, Gabarre J, Zouabi H, Sutton L, Boccaccio C, Albin N, Charlotte F, Merle-Béral H, Delort J, Binet JL, Leblond V.

Leuk Lymphoma. 1999 May;33(5-6):543-50.

PMID:
10342581
15.

Successful treatment of enteropathy-associated T cell lymphoma with autologous stem cell transplant.

Rongey C, Micallef I, Smyrk T, Murray J.

Dig Dis Sci. 2006 Jun;51(6):1082-6. No abstract available.

PMID:
16865575
16.
17.

Effective high-dose chemotherapy combined with CD34+-selected peripheral blood stem cell transplantation in a patient with cutaneous involvement of nasal NK/T-cell lymphoma.

Koizumi K, Fujimoto K, Haseyama Y, Endo T, Nishio M, Yokota K, Itoh T, Sawada K, Koike T.

Eur J Haematol. 2004 Feb;72(2):140-4.

PMID:
14962252
18.

A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas.

Romaguera JE, Rodriguez MA, Hagemeister FB, McLaughlin P, Swan F, Moore DF Jr, Sarris AH, Younes A, Hill D, Cabanillas F.

Invest New Drugs. 1994;12(3):217-22.

PMID:
7896540
19.

Prolonged remission of adult T-cell leukemia/lymphoma treated with interferon-gamma following autologous peripheral blood stem cell transplantation.

Ohno E, Ono K, Kikuchi H, Saburi Y, Utsunomiya A, Nasu M.

Leuk Lymphoma. 2005 Dec;46(12):1843-5. No abstract available.

PMID:
16263592
20.

[Comparison of salvage chemotherapy regimen ACES with ESHAP for refractory or relapsed malignant lymphoma].

Imataki O, Tamai Y, Kawakami K.

Gan To Kagaku Ryoho. 2007 Oct;34(10):1629-32. Japanese.

PMID:
17940378

Supplemental Content

Support Center